| Code | 08796 | ||||||||||
| MA number | 44/0640/70-CS | ||||||||||
| Product Form: | plv iol 1x100 mg+1x5 ml solv. (liek.inj.skl.+amp.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Subcutaneous and intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 30.12.1970 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_CYTOSAR 100 mg_02.2023.pdf
|
| PIL: |
PIL_CYTOSAR 100 mg_02.2023.pdf
|
| Safety feature | Yes |
| Data update: | 16.08.2022 |
